Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Pensri Pootrakul
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Disorders
Geographic Areas
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
18
Fucharoen, Suthat
9
Winichagoon, Pranee
9
Sirankapracha, Pornpan
8
Wasi, P
8
Piankijagum, Anong
5
Siritanaratkul, Noppadol
5
Macey, David
5
Hershko, Chaim
5
Breuer, William
5
Webb, John
5
St Pierre, Timothy
4
Cabantchik, Ioav
4
Chua-Anusorn, Wanida
4
Ong-ajyooth, Sompong
2
Malasit, Prida
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Pensri Pootrakul (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Metarugcheep Pichest; Chanyawattiwongs Somsak; Srisubat Kamolrat; Pootrakul Pensri
Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2008;91(6):889-94.
-
2007: Hackett S; Chua-anusorn W; Pootrakul P; St Pierre T G
The magnetic susceptibilities of iron deposits in thalassaemic spleen tissue.
Biochimica et biophysica acta 2007;1772(3):330-7.
-
2006: Mahachoklertwattana Pat; Pootrakul Pensri; Chuansumrit Ampaiwan; Choubtum Lulin; Sriphrapradang Arporn; Sirisriro Rojana; Rajatanavin Rajata
Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes.
Journal of bone and mineral metabolism 2006;24(2):146-52.
-
2005: St Pierre Timothy G; Clark Paul R; Chua-anusorn Wanida; Fleming Adam J; Jeffrey Gary P; Olynyk John K; Pootrakul Pensri; Robins Erin; Lindeman Robert
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.
Blood 2005;105(2):855-61.
-
2004: Jittangprasert Piyada; Wilairat Prapin; Pootrakul Pensri
Comparison of colorimetry and electrothermal atomic absorption spectroscopy for the quantification of non-transferrin bound iron in human sera.
The Southeast Asian journal of tropical medicine and public health 2004;35(4):1039-44.
-
2004: Pootrakul Pensri; Breuer William; Sametband Matias; Sirankapracha Pornpan; Hershko Chaim; Cabantchik Z Ioav
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator.
Blood 2004;104(5):1504-10.
-
2003: Unchern Supeenun; Laoharuangpanya Narumol; Phumala Noppawan; Sipankapracha Pornpan; Pootrakul Pensri; Fucharoen Suthat; Wanachivanawin Wanchai; Chantharaksri Udom
The effects of vitamin E on platelet activity in beta-thalassaemia patients.
British journal of haematology 2003;123(4):738-44.
-
2003: Esposito Breno P; Breuer William; Sirankapracha Pornpan; Pootrakul Pensri; Hershko Chaim; Cabantchik Z Ioav
Labile plasma iron in iron overload: redox activity and susceptibility to chelation.
Blood 2003;102(7):2670-7.
-
2003: Pootrakul Pensri; Sirankapracha Pornpan; Sankote Jongkal; Kachintorn Udom; Maungsub Wanna; Sriphen Kosit; Thakernpol Kleonphan; Atisuk Kanit; Fucharoen Suthat; Chantraluksri Udom; Shalev Oded; Hoffbrand A Victor
Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in Thailand.
British journal of haematology 2003;122(2):305-10.
-
2003: Phumala Noppawan; Porasuphatana Supatra; Unchern Supeenun; Pootrakul Pensri; Fucharoen Suthat; Chantharaksri Udom
Hemin: a possible cause of oxidative stress in blood circulation of beta-thalassemia/hemoglobin E disease.
Free radical research 2003;37(2):129-35.
-
2003: Hershko C; Abrahamov A; Konijn A M; Breuer W; Cabantchik I Z; Pootrakul P; Link G
Objectives and methods of iron chelation therapy.
Bioinorganic chemistry and applications 2003;():151-68.
-
2001: Breuer W; Ermers M J; Pootrakul P; Abramov A; Hershko C; Cabantchik Z I
Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy.
Blood 2001;97(3):792-8.
-
2000: Breuer W; Ermers M J; Pootrakul P; Abramov A; Hershko C; Cabantchik Z I
Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy.
Transfusion science 2000;23(3):241-2.
-
2000: Fucharoen S; Ketvichit P; Pootrakul P; Siritanaratkul N; Piankijagum A; Wasi P
Clinical manifestation of beta-thalassemia/hemoglobin E disease.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(6):552-7.
-
2000: Pootrakul P; Sirankapracha P; Hemsorach S; Moungsub W; Kumbunlue R; Piangitjagum A; Wasi P; Ma L; Schrier S L
A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia.
Blood 2000;96(7):2606-12.
-
1999: Wanachiwanawin W; Wiener E; Siripanyaphinyo U; Chinprasertsuk S; Mawas F; Fucharoen S; Wickramasinghe S N; Pootrakul P; Visudhiphan S
Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in beta(o)-thalassemia/HbE and their clinical significance.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(2):105-11.
-
1998: Ittarat W; Looareesuwan S; Pootrakul P; Sumpunsirikul P; Vattanavibool P; Meshnick S R
Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.
Antimicrobial agents and chemotherapy 1998;42(9):2332-5.
-
1998: St Pierre T G; Chua-anusorn W; Webb J; Macey D; Pootrakul P
The form of iron oxide deposits in thalassemic tissues varies between different groups of patients: a comparison between Thai beta-thalassemia/hemoglobin E patients and Australian beta-thalassemia patients.
Biochimica et biophysica acta 1998;1407(1):51-60.
-
1998: Fucharoen S; Winichagoon P; Siritanaratkul N; Chowthaworn J; Pootrakul P
Alpha- and beta-thalassemia in Thailand.
Annals of the New York Academy of Sciences 1998;850():412-4.
-
1998: Ong-ajyooth L; Malasit P; Ong-ajyooth S; Fucharoen S; Pootrakul P; Vasuvattakul S; Siritanaratkul N; Nilwarangkur S
Renal function in adult beta-thalassemia/Hb E disease.
Nephron 1998;78(2):156-61.
-
1997: Chua-anusorn W; Webb J; Macey D J; Pootrakul P; St Pierre T G
The effect of histological processing on the form of iron in iron-loaded human tissues.
Biochimica et biophysica acta 1997;1360(3):255-61.
-
1996: Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter A N; Rodgers G P
Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
Blood 1996;87(3):887-92.
-
1995: Ongajyooth L; Siritanaratkul N; Pootrakul P; Parichatikanond P; Malasit P; Fucharoen S; Nimmannit S; Piankijagum A; Nilwarangkur S
Glomerulonephritis in beta-thalassemia Hb-E disease: clinical manifestations, histopathologic studies and outcome.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1995;78(3):119-26.
-
1991: Wanachiwanawin W; Pootrakul P; Fucharoen S; Piankijagum A
High-dose intravenous immunoglobulin in the management of immune hemolysis in patients with thalassemic disease: factors which determine refractoriness.
The Southeast Asian journal of tropical medicine and public health 1991;22(3):397-401.
-
1991: Suthipark K U; Likidlilid A; Fucharoen S; Pootrakul P; Shumnumsirivath D; Ong-ajyooth S; Plaskett D; Webb J
Red cell and plasma calcium, copper and zinc in beta-thalassemia/hemoglobin E.
The Southeast Asian journal of tropical medicine and public health 1991;22(2):171-5.
-
1991: Vannasaeng S; Fucharoen S; Pootrakul P; Ploybutr S; Yansukon P
Pituitary function in thalassemic patients and the effect of chelation therapy.
Acta endocrinologica 1991;124(1):23-30.
-
1991: St Pierre T G; Tran K C; Webb J; Macey D J; Heywood B R; Sparks N H; Wade V J; Mann S; Pootrakul P
Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E.
Biology of metals 1991;4(3):162-5.
-
1990: Huebers H A; Beguin Y; Pootrakul P; Einspahr D; Finch C A
Intact transferrin receptors in human plasma and their relation to erythropoiesis.
Blood 1990;75(1):102-7.
-
1990: Tran K C; Webb J; Macey D J; Pootrakul P
Beta-thalassaemia/haemoglobin E tissue ferritins. II: A comparison of heart and pancreas ferritins with those of liver and spleen.
Biology of metals 1990;3(3-4):227-31.
-
1990: Tran K C; Webb J; Macey D J; Pootrakul P; Yansukon P
Beta-thalassaemia/haemoglobin E tissue ferritins. I: Purification and partial characterization of liver and spleen ferritins.
Biology of metals 1990;3(3-4):222-6.
-
1988: Charoenlarp P; Srinophakhun S; Pootrakul P; Polpothi T; Chatpunyaporn P
Investigation of the causes of suboptimal haemoglobin response to iron supplementation.
The Southeast Asian journal of tropical medicine and public health 1988;19(2):291-7.
-
1988: Pootrakul P; Kitcharoen K; Yansukon P; Wasi P; Fucharoen S; Charoenlarp P; Brittenham G; Pippard M J; Finch C A
The effect of erythroid hyperplasia on iron balance.
Blood 1988;71(4):1124-9.
-
1988: Pootrakul P; Josephson B; Huebers H A; Finch C A
Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron.
Blood 1988;71(4):1120-3.
-
1988: Charoenlarp P; Dhanamitta S; Kaewvichit R; Silprasert A; Suwanaradd C; Na-Nakorn S; Prawatmuang P; Vatanavicharn S; Nutcharas U; Pootrakul P
A WHO collaborative study on iron supplementation in Burma and in Thailand.
The American journal of clinical nutrition 1988;47(2):280-97.
-
1988: Pootrakul P; Huebers H A; Finch C A; Pippard M J; Cazzola M
Iron metabolism in thalassemia.
Birth defects original article series 1988;23(5B):3-8.
-
1987: Cazzola M; Pootrakul P; Bergamaschi G; Huebers H A; Eng M; Finch C A
Adequacy of iron supply for erythropoiesis: in vivo observations in humans.
The Journal of laboratory and clinical medicine 1987;110(6):734-9.
-
1987: Pootrakul P; Yansukon P; Thongmee A; Finch C A
A mild uncompensated alkalosis in anemia.
The American journal of the medical sciences 1987;294(6):408-11.
-
1987: Vannasaeng S; Fucharoen S; Nitiyanant W; Vichayanrat A; Pootrakul P; Piraphatdist T
Impaired glucose counterregulation after insulin-induced hypoglycemia in thalassemic patients.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1987;70(11):631-7.
-
1987: Ong-Ajyooth S; Suthipark K; Shumnumsirivath D; Likidlilid A; Fucharoen S; Pootrakul P
Oxidative stress and antioxidants in beta-thalassaemia/haemoglobin E.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1987;70(5):270-4.
-
1987: Huebers H A; Eng M J; Josephson B M; Ekpoom N; Rettmer R L; Labbé R F; Pootrakul P; Finch C A
Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methods.
Clinical chemistry 1987;33(2 Pt 1):273-7.
-
1987: Cazzola M; Pootrakul P; Huebers H A; Eng M; Eschbach J; Finch C A
Erythroid marrow function in anemic patients.
Blood 1987;69(1):296-301.
-
1987: Fucharoen S; Winichagoon P; Prayoonwiwat W; Pootrakul P; Piankijagum A; Wasi P
Clinical and hematologic manifestations of AE Bart disease.
Birth defects original article series 1987;23(5A):327-32.
-
1987: Fucharoen S; Winichagoon P; Pootrakul P; Piankijagum A; Wasi P
Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb constant spring.
Birth defects original article series 1987;23(5A):309-15.
-
1987: Fucharoen S; Winichagoon P; Pootrakul P; Piankijagum A; Wasi P
Variable severity of Southeast Asian beta 0-thalassemia/Hb E disease.
Birth defects original article series 1987;23(5A):241-8.
-
1987: Suthipark K; Ong-ajyooth S; Shumnumsirivath D; Likidlilid A; Fucharoen S; Siddhikol C; Pootrakul P; Niyomporn B
Oxidative stress and antioxidants in beta-thalassemia/hemoglobin E.
Birth defects original article series 1987;23(5A):199-205.
-
1985: Wasi P; Pootrakul P; Fucharoen S; Winichagoon P; Wilairat P; Promboon A
Thalassemia in southeast Asia: determination of different degrees of severity of anemia in thalassemia.
Annals of the New York Academy of Sciences 1985;445():119-26.
-
1984: Fucharoen S; Winichagoon P; Pootrakul P; Wasi P
Determination for different severity of anemia in thalassemia: concordance and discordance among sib pairs.
American journal of medical genetics 1984;19(1):39-44.
-
1981: Pootrakul P; Winichagoon P; Fucharoen S; Pravatmuang P; Piankijagum A; Wasi P
Homozygous haemoglobin Constant Spring: a need for revision of concept.
Human genetics 1981;59(3):250-5.
-
1980: Wasi P; Pootrakul S; Pootrakul P; Pravatmuang P; Winichagoon P; Fucharoen S
Thalassemia in Thailand.
Annals of the New York Academy of Sciences 1980;344():352-63.
Sign-in to see more
